Milestone Pharmaceuticals Inc.
MIST | NASDAQ
$0.92
$0 (+0.46%)
At close: Sep 21, 2026, 4:00 PM ET
$0.92
$0 (-0.24%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.55M | n/a | 1M | 5M | 15M | n/a |
Cost of Revenue | 114K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 1.43M | n/a | 1M | 5M | 15M | n/a |
Operating Income | -62.49M | -42.1M | -61.1M | -59.64M | -43.07M | -50.71M |
Interest Income | 2.92M | 4.16M | 3.97M | 1.25M | 220K | 726K |
Pretax Income | -63.4M | -41.52M | -59.69M | -58.39M | -42.85M | -49.98M |
Net Income | -63.06M | -41.52M | -59.69M | -58.39M | -42.85M | -49.97M |
Selling & General & Admin | 17.27M | 27.75M | 31.05M | 24.81M | 19.4M | 15.9M |
Research & Development | 18.11M | 14.36M | 31.05M | 39.83M | 38.67M | 34.86M |
Other Expenses | 28.54M | n/a | n/a | n/a | n/a | -55K |
Operating Expenses | 63.92M | 42.1M | 62.1M | 64.64M | 58.07M | 50.71M |
Interest Expense | 3.84M | -3.58M | 2.55M | n/a | n/a | 726K |
Selling & Marketing Expenses | n/a | 11M | 15.11M | 9.1M | 7M | 5.94M |
Cost & Expenses | 64.03M | 42.1M | 62.1M | 64.64M | 58.07M | 50.71M |
Income Tax Expense | -345K | n/a | n/a | n/a | n/a | -17K |
Shares Outstanding (Basic) | 83.88M | 62.21M | 42.96M | 42.45M | 41.83M | 29.34M |
Shares Outstanding (Diluted) | 83.88M | 62.21M | 42.96M | 42.45M | 41.83M | 29.34M |
EPS (Basic) | -0.75 | -0.67 | -1.39 | -1.35 | -1.02 | -1.70 |
EPS (Diluted) | -0.75 | -0.67 | -1.39 | -1.35 | -1.02 | -1.70 |
EBITDA | -59.45M | -37.83M | -57.04M | -58.3M | -42.76M | -50.61M |
EBIT | -59.57M | -37.94M | -57.13M | -58.39M | -42.85M | -50.71M |
Depreciation & Amortization | 114K | 105K | 92K | 89K | 93K | 97K |
Add to Watchlist
Select watchlists to add or remove MIST